2016
DOI: 10.1055/s-0036-1592171
|View full text |Cite
|
Sign up to set email alerts
|

Multimodality Monitoring: Illuminating the Comatose Human Brain

Abstract: The field of neurocritical care has evolved tremendously in recent years, a development explained vastly by the advent of neurophysiological monitoring. From basic intracranial pressure measurements to brain tissue oxygenation, microdialysis, cerebral blood flow (CBF), and surface and intracortical electroencephalography (EEG), our ability to detect and control physiologic endpoints of brain function in comatose patients has grown substantially. The integration of these data gave birth to the concept of multim… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 54 publications
(59 reference statements)
0
1
0
Order By: Relevance
“…Disease-specific practice surveys from Europe and Latin America have focused on MNM for traumatic brain injury (TBI) (6)(7)(8). Narrative reviews of invasive and noninvasive MNM (9)(10)(11)(12)(13)(14)(15), or MNM for patients with TBI (16,17), aneurysmal subarachnoid hemorrhage (aSAH) (18,19), and cardiac arrest (20) also exist. Yet, there remains no consensus regarding: a) the minimum set of technologies required for MNM, b) which patients may benefit from care guided by MNM, c) the effort required to integrate MNM measurements and interpret the resulting data, and d) the training required to understand and accurately interpret MNM information.…”
mentioning
confidence: 99%
“…Disease-specific practice surveys from Europe and Latin America have focused on MNM for traumatic brain injury (TBI) (6)(7)(8). Narrative reviews of invasive and noninvasive MNM (9)(10)(11)(12)(13)(14)(15), or MNM for patients with TBI (16,17), aneurysmal subarachnoid hemorrhage (aSAH) (18,19), and cardiac arrest (20) also exist. Yet, there remains no consensus regarding: a) the minimum set of technologies required for MNM, b) which patients may benefit from care guided by MNM, c) the effort required to integrate MNM measurements and interpret the resulting data, and d) the training required to understand and accurately interpret MNM information.…”
mentioning
confidence: 99%